FDA Approves Weight Loss Drug Wegovy for Liver Disease

Contact Your Elected Officials

About 6 percent of American adults have the disease, known as MASH.

The Food and Drug Administration has approved a weight loss drug called Wegovy for a liver disease, the agency announced on Aug. 18.

Wegovy is now approved for treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that impacts approximately 6 percent of American adults, the FDA said in a statement.

Updated labeling for Wegovy now lists the treatment.

“The indication for MASH is approved under accelerated approval based on improvement of MASH and fibrosis,” it states. “Continued approval for this indication may be contingent upon the verification and description of clinical benefit in a confirmatory trial.”

Data supporting the approval came from an interim analysis, at week 72, from a phase 3 double-blind, placebo-controlled trial that’s designed to last for 240 weeks. Patients who received Wegovy were more likely to experience improvement in liver scarring, with no worsening of liver disease.

MASH is also known as nonalcoholic fatty liver disease. The condition can develop in obese people and occurs when fat builds up in one’s liver. That causes inflammation, and can lead to severe problems such as liver cancer unless treated.

Wegovy was already approved for reducing weight in people who are at least 12 years of age “in combination with a reduced calorie diet and increased physical activity.”

It is also cleared for the reduction of cardiovascular events in adults who are oversight or obese, and have cardiovascular disease.

Wegovy is one of several glucagon-like peptide-1 (GLP-1) drugs that have been approved in recent years for weight loss and other purposes. The FDA initially approved Wegovy in 2021 for adults.

Side effects can include thyroid tumors and pancreatic inflammation.

Novo Nordisk, a European manufacturer, makes Wegovy and a similar product, Ozempic, both also known as semaglutide.

“Wegovy is now uniquely positioned as the first and only GLP-1 treatment approved for MASH, complementing the already proven weight loss, cardiovascular benefits and extensive body of evidence linked to semaglutide,” Martin Holst Lange, chief scientific officer at Novo Nordisk, said in a statement.

By Zachary Stieber

Read Full Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

A Reluctant Acknowledgment: What Conservatives Can Admire in Everyday Progressives

Admirable ideological qualities seen in liberals and left-wing individuals are those of the everyday believer not their political leadership.

Ensuring Domestic Tranquility

The Supremacy Clause in Article VI of the U.S. Constitution establishes it as the highest law of the land, taking precedence over conflicting state laws.

Pam Bondi, Zohran Mamdani, and the ADL: Censorious Peas in a Pod

Typically, the only four circumstances under which the leadership...

Shut it Down – Shut it Down

Shut down and dismantle every federal agency not essential to citizens' life, health, or liberty — phase them out and end their power. permanently!

Conservatism’s Diverse Meanings

Conservatives in America often seem united, but major differences exist, creating the false impression that "conservative" means the same to everyone..

Trump Weighs on Cutting Agencies as Government Shutdown Enters Day 2

Trump to meet with OMB Dir. Vought to decide which agencies face cuts and whether reductions will be temporary or permanent.

Is There a 9/11 WTC and 9/10 Charlie Kirk Connection?

Strange parallels in online stories raise questions about whether Israelis and Mossad intelligence are our allies or adversaries.

Pam Bondi, Zohran Mamdani, and the ADL: Censorious Peas in a Pod

Typically, the only four circumstances under which the leadership...

Impact of Government Shutdown on Social Security: What to Know

SSA made it clear that retirement, survivor, and disability benefits are not subject to annual budget fights and will continue to be paid on time.

White House Withdraws EJ Antoni’s Nomination to Lead Bureau of Labor Statistics

The White House has withdrawn economist EJ Antoni’s nomination to lead the Bureau of Labor Statistics, the White House confirmed on Sept. 30.

US to Impose 100 Percent Tariffs on Foreign-Made Movies, Trump Says

President Donald Trump announced on Sept. 29 that he will impose a 100 percent tariff on all movies produced outside the United States.

Trump to Host Netanyahu at White House to Discuss Gaza Peace Plan

President Trump will host Israeli Prime Minister Netanyahu at the White House on Sept. 29 to discuss a ceasefire and broader peace plan for Gaza.

Trump Announces New Tariffs on Heavy Trucks, Drugs, Kitchen Cabinets, Other Products

President Trump will impose new tariffs next month on heavy trucks, branded drugs, kitchen cabinets, bathroom vanities, and related products.
spot_img

Related Articles

Popular Categories

MAGA Business Central